Trial Profile
A study evaluating safety and efficacy of perampanel as an adjunctive therapy in patients with Lafora disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Lafora disease
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2016 New trial record